{"favorite_id": 10116, "calc_type": "calculator", "dosing": false, "full_title_en": "TNM Staging for Hepatocellular Carcinoma (HCC) (8th Edition)", "short_title_en": "TNM HCC Staging (8th Ed.)", "medium_description_en": "Stages HCC based on tumor, lymph nodes, and metastases (recommended as of 2017).", "short_description_en": "HCC staging, recommended as of 2017.", "before_use": "", "instructions_en": "", "purpose_en": ["Diagnosis", "Prognosis"], "disease_en": ["Cancer", "Chemotherapy", "Cirrhosis", "Hepatocellular Carcinoma"], "specialty_en": ["Gastroenterology", "Hematology and Oncology", "Hepatology", "Hospitalist Medicine", "Internal Medicine", "Surgery (General)"], "chief_complaint_en": ["Abdominal Pain", "Weakness", "Jaundice"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["liver cancer", "TNM", "tumour", "Tumor", "lymphadenectomy", "stage", "cancer", "hcc", "lymph nodes", "8th edition", "hepatocellular cancer", "8th ed", "TNM HCC"], "slug": "tnm-staging-hepatocellular-carcinoma-hcc-8th-edition", "seo": {"meta_description_en": "The TNM Staging for Hepatocellular Carcinoma (HCC) (2017) stages hepatocellular carcinoma based on tumor, lymph node, and metastasis characteristics.", "keywords_en": "TNM Staging for hepatocellular cancer, hepatocellular cancer, hepatocellular ca, pancreas cancer, pancreas ca, panc ca tnm, hepatocellular cancer tnm, hepatocellular cancer staging, hepatocellular, ca, cancer, carcinoma, hcc, liver, chronic, Tumor, tumour, liver cancer, lymph nodes, lymphadenectomy, stage, 8th edition, 8th ed, tnm"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-36bc3176-7fff-3a60-90c5-92b288b3ff7a\">Patients diagnosed with HCC, including fibrolamellar HCC, who have undergone surgical resection.</p>", "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-f8a1b3d7-7fff-637b-5cbf-fa7e535e808e\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Stages HCC by tumor, nodes, and metastasis characteristics.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Requires pathologic specimen for evaluation, thus limiting its use since most HCC patients do not undergo surgical resection.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Does not account for liver function, which is a known prognostic factor in HCC and cirrhosis.</p>\n</li>\n</ul>", "why_use_en": "<p><span id=\"docs-internal-guid-491a4f63-7fff-916e-8264-e436e9d77851\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Gives prognosis of HCC when pathologic data is available.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Barcelona Clinic Liver Cancer (BCLC) staging may be more clinically useful, as it incorporates liver function and patient functional status, and does not require a pathologic specimen.</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<p><span id=\"docs-internal-guid-e4a45a88-7fff-c0ab-1359-cbf40dd33e80\"></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><a href=\"https://www.nccn.org/professionals/physician_gls/default.aspx\" target=\"_blank\">National Comprehensive Cancer Network (NCCN) guidelines</a> use TNM staging for treatment recommendations, but note that many staging systems exist, all have limitations, and some are region-dependent.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Can only be used if patient has had surgical resection.</p>\n</li>\n</ul>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<div dir=\"ltr\">\n<table><colgroup><col width=\"41\" /><col width=\"167\" /><col width=\"104\" /><col width=\"141\" /></colgroup>\n<tbody>\n<tr>\n<td colspan=\"4\">\n<p dir=\"ltr\"><strong>Primary tumor (T)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Tx</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Primary tumor cannot be assessed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">T0</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">No evidence of primary tumor</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">T1</p>\n</td>\n<td>\n<p dir=\"ltr\">Solitary tumor &le;2 cm or &gt;2 cm without vascular invasion</p>\n</td>\n<td colspan=\"2\">\n<p dir=\"ltr\">T1a: Solitary tumor &le;2 cm</p>\n<p dir=\"ltr\">T1b: Solitary tumor &gt;2 cm without vascular invasion</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">T2</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Solitary tumor &gt;2 cm with vascular invasion, or multiple tumors (none &gt;5 cm)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">T3</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Multiple tumors, at least one of which is &gt;5 cm</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">T4</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Single or multiple tumor(s) of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p dir=\"ltr\"><strong>Regional lymph node (N)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Nx</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Regional lymph nodes cannot be assessed</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">N0</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">No regional lymph node metastasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">N1</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Regional lymph node metastasis</p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\">\n<p dir=\"ltr\"><strong>Distant metastasis (M)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">M0</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">No distant metastasis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">M1</p>\n</td>\n<td colspan=\"3\">\n<p dir=\"ltr\">Distant metastasis</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"112\" /><col width=\"88\" /><col width=\"99\" /><col width=\"99\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>Prognostic stage group</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>T</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>N</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>M</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IA</p>\n</td>\n<td>\n<p dir=\"ltr\">T1a</p>\n</td>\n<td>\n<p dir=\"ltr\">N0</p>\n</td>\n<td>\n<p dir=\"ltr\">M0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IB</p>\n</td>\n<td>\n<p dir=\"ltr\">T1b</p>\n</td>\n<td>\n<p dir=\"ltr\">N0</p>\n</td>\n<td>\n<p dir=\"ltr\">M0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">II</p>\n</td>\n<td>\n<p dir=\"ltr\">T2</p>\n</td>\n<td>\n<p dir=\"ltr\">N0</p>\n</td>\n<td>\n<p dir=\"ltr\">M0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIIA</p>\n</td>\n<td>\n<p dir=\"ltr\">T3</p>\n</td>\n<td>\n<p dir=\"ltr\">N0</p>\n</td>\n<td>\n<p dir=\"ltr\">M0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IIIB</p>\n</td>\n<td>\n<p dir=\"ltr\">T4</p>\n</td>\n<td>\n<p dir=\"ltr\">N0</p>\n</td>\n<td>\n<p dir=\"ltr\">M0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IVA</p>\n</td>\n<td>\n<p dir=\"ltr\">Any T</p>\n</td>\n<td>\n<p dir=\"ltr\">N1</p>\n</td>\n<td>\n<p dir=\"ltr\">M0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">IVB</p>\n</td>\n<td>\n<p dir=\"ltr\">Any T</p>\n</td>\n<td>\n<p dir=\"ltr\">Any N</p>\n</td>\n<td>\n<p dir=\"ltr\">M1</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "evidence_based_medicine_en": "<p><span id=\"docs-internal-guid-1eb4ee44-7fff-32f6-83e6-2dc04c8cbcaa\">The TNM staging system for HCC, like all TNM staging systems, was developed by the American Joint Committee on Cancer (AJCC).</span></p>", "references_list": {"Original/Primary Reference": [{"href": "https://cancerstaging.org/references-tools/deskreferences/Pages/default.aspx", "text": "American Joint Committee on Cancer (AJCC). AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017."}], "Other References": [{"href": "", "text": ""}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/17304512", "text": "Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, Cheng YF, Hsu HC, Wang CC, Chen TY, Lin CY, Lu SN. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007 Jun 15;120(12):2650-5."}, {"href": "https://www.ncbi.nlm.nih.gov/pubmed/23703450", "text": "Kee KM, Wang JH, Lin CY, Wang CC, Cheng YF, Lu SN. Validation of the 7th edition TNM staging system for hepatocellular carcinoma: an analysis of 8,828 patients in a single medical center. Dig Dis Sci. 2013 Sep;58(9):2721-8."}], "Clinical Practice Guidelines": [{"href": "https://www.nccn.org/professionals/physician_gls/default.aspx", "text": "National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. Version 2; 2018."}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Ghassan K. Abou-Alfa", "creator_info": {"about_en": "Ghassan K. Abou-Alfa, MD, is a medical oncologist at Memorial Sloan Kettering Cancer Center. He is also chair of the National Cancer Institute (NCI) Task Force for Hepatobiliary Cancers. Dr. Abou-Alfa\u2019s primary research is focused on small molecule-based therapy for hepatobiliary and pancreatic cancers.", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-ghassan-k-abou-alfa.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Abou-Alfa+GK%5Bau%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Primary tumor (T)", "name": "t", "options": [{"label": "Primary tumor cannot be assessed", "value": -1}, {"label": "No evidence of primary tumor", "value": 0}, {"label": "Solitary tumor \u22642 cm or >2 cm without vascular invasion", "value": 1}, {"label": "Solitary tumor >2 cm with vascular invasion, or multiple tumors (none >5 cm)", "value": 2}, {"label": "Multiple tumors, at least one of which is >5 cm", "value": 3}, {"label": "Single or multiple tumor(s) of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum", "value": 4}], "conditionality": "", "show_points": false, "default": 1, "optional": false}, {"type": "radio", "label_en": "T1", "name": "t1", "options": [{"label": "Solitary tumor \u22642 cm", "value": 0}, {"label": "Solitary tumor >2 cm without vascular invasion", "value": 1}], "conditionality": "t==1", "show_points": false, "optional": false}, {"type": "radio", "label_en": "Regional lymph node (N)", "name": "n", "options": [{"label": "Regional lymph nodes cannot be assessed", "value": -1}, {"label": "No regional lymph node metastasis", "value": 0}, {"label": "Regional lymph node metastasis", "value": 1}], "conditionality": "", "show_points": false, "default": 1, "optional": false}, {"type": "radio", "label_en": "Distant metastasis (M)", "name": "m", "options": [{"label": "No distant metastasis", "value": 0}, {"label": "Distant metastasis", "value": 1}], "conditionality": "", "show_points": false, "default": 0, "optional": false}], "md5": "fa45ce962e73933738cf9c1a30270f3a", "related_calcs": [{"calcId": 10113, "short_title_en": "TNM Melanoma Staging (8th Ed.)", "slug": "tnm-staging-melanoma-8th-edition"}, {"calcId": 10178, "short_title_en": "TNM Pancreatic CA Staging (8th Ed.)", "slug": "tnm-staging-pancreatic-cancer-8th-edition"}, {"calcId": 3974, "short_title_en": "TNM Melanoma Staging", "slug": "tnm-staging-melanoma"}]}